InfuSystem Holdings, Inc.

AMEX:INFU

Medical - Instruments & Supplies

Healthcare
$14.67 +4.00%

+$0.35 today

Market cap
$293.89M
Beta
1.42
P/E (TTM)
23.2
EPS (TTM)
$0.39
52W Low $5.38High $11.04

Volume 0.16M

Average 0.16M

INFU Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

InfuSystem Holdings, Inc.AMEX: INFU

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit grows, but more slowly than its trailing trend

Q1 FY2026 gross profit of $19.68M rose 2.7% year over year, behind the +10.6% change in trailing-twelve-month gross profit. Sequentially, it fell 3.7% from the prior quarter. Over 3 fiscal years it compounded at +9.9% a year.

Context

  • Gross profit amounted to 56.0% of revenue in FY2025, up 3.8 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.7% toward the trailing-twelve-month pace of +10.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$19.68M-3.7% QoQ
Last fiscal yearDec 2025
$80.3M+14.1% YoY
LTMMar 2026
$80.81M+10.6% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.7%——
1 year+14.1%——
3-year CAGR+9.9%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
80.3M USD
Year-over-year change
+14.1%
4-year CAGR
+8.2%

Gross Profit vs competitors

How INFU compares with its peers on the latest reported figures

  • INFU's LTM Mar 2026 gross profit of $80.81M is the 2nd highest of the 3 companies compared; the peer median is $418.88M.
  • Its year-over-year change of +10.6% is the 2nd highest of 3, against a peer median of +7.4%.
  • Gross profit amounts to 56.7% of revenue for INFU, versus a peer median of 49.5%.
INFU Competitors Peer median
Gross Profit for INFU and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ICUIICU Medical, Inc.LTM Jun 2026$811.16M -4.6%+5.5%37.6%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$80.81M +10.6%+9.9%56.7%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$26.59M +19.4%+18.5%61.5%
Peer median (excluding INFU) $418.88M+7.4%+12.0%49.5%

Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue102.38M109.91M125.79M134.86M143.44M
Cost of Revenue43.85M49.35M62.68M64.46M63.14M
Gross Profit58.54M60.56M63.11M70.4M80.3M
Gross Margin57.2%55.1%50.2%52.2%56.0%
Research & Development00000
Selling, General & Admin51.45M56.41M58.03M62.52M67.46M
Operating Expenses55.72M58.91M59.02M63.51M68.38M
Depreciation & Amortization14.63M13.36M12.51M12.5M13.29M
EBITDA17.26M14.89M16.53M20.03M25.22M
EBITDA Margin16.9%13.5%13.1%14.9%17.6%
Operating Income2.82M1.65M4.09M6.89M11.92M
Operating Margin2.8%1.5%3.2%5.1%8.3%
Interest Income00000
Interest Expense1.38M1.4M2.17M1.78M1.3M
Other Income / Expenses(1.56M)(1.52M)(2.24M)(1.83M)(1.3M)
Income Before Tax1.26M130K1.85M5.06M10.62M
Pre-Tax Margin1.2%0.1%1.5%3.8%7.4%
Income Tax Expense(163K)112K979K2.71M4M
Net Income1.42M18K872K2.35M6.63M
Net Margin1.4%0.0%0.7%1.7%4.6%
EPS (Basic)0.070.000.040.110.32
EPS (Diluted)0.060.000.040.110.31
Weighted Avg Shares20.52M20.65M21.02M21.27M20.66M
Weighted Avg Shares (Diluted)22.05M21.55M21.65M21.71M21.1M

InfuSystem Holdings, Inc.

AMEX:INFU

Intrinsic Alpha fair value

Locked

Current Price

$14.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.